Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis

Breast Cancer Research and Treatment

Volumn 73, Issue 1, 2002, Pages 75-83

  Sivaraman, Lakshmi ^a   Gay, Jason ^a   Hilsenbeck, Susan G ^a   Shine, H David ^b,c,d   Conneely, Orla M ^a   Medina, Daniel ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Department of Molecular and Cellular Biology ^*  (United States)

^c Division of Neuroscience   (United States)

^d CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Adv RSV tk GCV; Carcinogenesis; Mammary gland; MNU; Proliferating cells

Indexed keywords

ADENOVIRUS VECTOR; BRCA1 PROTEIN; BRCA2 PROTEIN; GANCICLOVIR; KI 67 ANTIGEN; METHYLNITROSOUREA; THYMIDINE KINASE; VIRUS PROTEIN; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTIVIRUS AGENT; BETA GALACTOSIDASE; CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER INCIDENCE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS REPLICATION; ADENOVIRUS; ANIMAL; CELL DIVISION; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INCIDENCE; INTRALESIONAL DRUG ADMINISTRATION; METABOLISM; UDDER; WISTAR FURTH RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOVIRIDAE; ANIMAL; ANTIVIRAL AGENTS; BETA-GALACTOSIDASE; CARCINOGENS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOENZYME TECHNIQUES; INCIDENCE; INJECTIONS, INTRALESIONAL; MAMMAE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; RATS; RATS, INBRED WF; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDINE KINASE; ANIMALS; MAMMARY GLANDS, ANIMAL;

EID: 0035985487     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015227719105     Document Type: Article

References (40)

1. The epidemiology of breast cancer
2. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
3. Cancer Statistics, 2001
4. Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families
5. The prevention of breast cancer: An overview
6. Contralateral prophylactic mastectomy in women with a personal and family history of breast cancer
7. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
8. Tamoxifen to raloxifene and beyond
9. Breast cancer prevention trials
10. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P- 1 Study
11. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial. Multiple outcomes of raloxifene evaluation
12. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation
13. Reconstitution of estrogen-dependent transcriptional activation of an adenoviral target gene in select regions of the rat mammary gland
14. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence
15. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis
16. The mammary gland: A unique organ for the study of development and tumorigenesis
17. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpes-viruses in vitro and its mode of action against herpes simplex virus type 1
18. S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase
19. Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues
20. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy
21. Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro
22. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
23. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer
24. Transgenic mice with inducible dwarfism
25. Genetic ablation of parietal cells in transgenic mice: A new model for analyzing cell lineage relationships in the gastric mucosa
26. Targeted ablation of pituitary gonadotropes in transgenic mice
27. Selective cell ablation in transgenic mice expression E. coli nitroreductase
28. Nitroreductase-mediated cell ablation is very rapid and mediated by a p53-independent apoptotic pathway
29. Accessibility and possibility of elimination of breast epithelium: The theoretical possibility of preventing breast carcinoma through destruction of the epithelium of origin
30. Adenovirus type 9-induced tumorigenesis in the rat mammary gland related to sex hormonal state
31. ROSA26 mice carry a modifier of Min-induced mammary and intestinal tumor development
32. Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation
33. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
34. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat
35. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
36. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
37. Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells
38. Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA